BYOT Byotrol Plc

 

TIDMBYOT 
 
RNS Number : 1675J 
Byotrol PLC 
25 March 2010 
 

 
                                                                   25 March 2010 
 
                                  Byotrol plc 
                               Directorate change 
 
The Board of Byotrol plc ('Byotrol' or the 'Company'), the leading 
anti-microbial hygiene company, is pleased to announce the appointment of Dr. 
Gary Millar as the Company's new Chief Executive Officer.  Dr. Millar will join 
the Company on 1 April 2010. 
 
Dr. Millar, aged 48, has a PhD in Biochemistry from Glasgow University.  He 
started his career with ICI plc, where he held several senior managerial 
positions. 
 
In 1998 Dr. Millar joined the Foseco division of Burmah Castrol plc as Supply 
Chain Director and was subsequently appointed Operations Director of Foseco 
Jersey Ltd., a private equity backed MBO, which floated on the London Stock 
Exchange in 2005.  Between 2005 - 2007, Dr Millar was Managing Director of 
Foseco Steel UK Ltd.  In 2007 Dr Millar was appointed Group Services Director of 
Foseco plc, and was a member of Foseco plc's Executive Committee, where he 
played a key role in Foseco's merger with Cookson plc. 
 
In 2008 Dr. Millar founded A K Business Management Limited, a management 
consultancy providing strategic marketing and operational business solutions to 
UK SMEs. 
 
Dr. Millar is a full member of the Chartered Institute of Marketing and is a 
member of the Institute of Directors. 
 
David McRobbie, Byotrol's current CEO, will remain on the Company board with 
responsibility for the important US operations, and will re-locate to the USA 
later this year as CEO of Byotrol Inc. 
 
Commenting on the appointments, Ralph Kugler, Chairman, said: 
 
"The Board of Directors is delighted to welcome Gary Millar as its new Chief 
Executive Officer.  Gary has had an outstanding career, and combines strong 
senior management achievement with experience of the Life Sciences sector.  Gary 
has led both small and large businesses, and has an impressive track record of 
delivering results." 
 
"The Board is also pleased that David McRobbie has agreed to relocate to the US 
to lead Byotrol Inc.  Success in the US is a key part of our strategy, and the 
Board is clear that this can only be achieved with experienced senior 
leadership.  Mr McRobbie will continue to be a member of the Byotrol plc board." 
 
 
Details of directorships that Dr. Millar holds, or has held in the previous five 
years, are given below: 
 
Current directorships: 
 
AK Business Management Ltd 
 
Past directorships: 
 
Foseco plc 
Foseco (GB) Limited 
Foseco (Jersey) Limited 
Foseco (MRL) Limited 
Foseco (RUL) Limited 
Foseco (UK) Limited 
Foseco Holding (Europe) Limited 
Foseco Holding B.V. 
Foseco Holding International Limited 
Foseco Holding Limited 
Foseco International Limited 
Foseco Limited 
Foseco Overseas Limited 
Foseco Pension Fund Trustee Limited 
Foseco Steel (Holdings) China Limited 
Foseco Steel (UK) Limited 
Foseco Technology Limited 
Foseco Transnational Limited 
Minerals Separation Limited 
New Foseco (UK) Limited 
Tamworth UK Limited 
Unicorn Industries Limited 
 
 
Save for the declarations above there is no further information to be disclosed 
in respect of the appointment of Dr. Millar under Rule 17 or Schedule Two 
paragraph (g) of the AIM Rules for Companies. 
 
 
Enquiries: 
 
Byotrol plc 
                          0161 277 9518 
Ralph Kugler, Non-Executive Chairman 
Richard Bell, Finance Director 
 
 
Charles Stanley Securities 
               020 7149 6000 
Nominated Adviser 
Russell Cook / Carl Holmes 
 
Winningtons 
                       020 3043 4162 
Tom Cooper / Paul Vann 
              0797 122 1972 
 
 
Notes to Editors: 
 
Byotrol Plc (BYOT.L), quoted on AIM, is a leading microbial technology hygiene 
company, operating globally in the Health, Food, Leisure, Consumer, Industrial 
and Agriculture sectors, providing a low toxicity product with a broad-based and 
long lasting efficacy across all microbial classes; bacteria, viruses, fungi, 
moulds, microbacteria and algae. 
 
The Byotrol product can be used as a stand alone product or as a complementary 
biocide additive to existing products to improve their performance in personal 
hygiene, domestic and industrial disinfection, odour control, food production 
and food management. 
 
Founded in 2005, the Company has prioritised the development of a technology 
that creates easier, safer and cleaner lives through partnering with providers 
of essential goods and services.  Byotrol is the catalyst behind the aptly named 
global 'Hygiene Revolution'. 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 BOAEANDSAELEEEF 
 

Grafico Azioni Byotrol (LSE:BYOT)
Storico
Da Giu 2024 a Lug 2024

Grafico Azioni Byotrol (LSE:BYOT)
Storico
Da Lug 2023 a Lug 2024